Aethlon Medical, Inc. (OTCBB:AEMD) Attracts Attention

7AEMD_chart.pngAehtlon Medical, Inc. (OTCBB:AEMD) is one of those medical companies in the OTC markets whose stock rarely gets high dollar volume. The ticker has been descending the charts from the beginning of the year, but things have changed in the past sessions.

On March 5, the company made a press release announcing a discovery they have made that might help identify and cure chronic traumatic encephalatopathy (CTE), which can be only diagnosed postmortem at the moment, and help patients with traumatic brain injury, Alzheimer’s and other neurodegenerative disorders.

They say that they have isolated brain-specific biomarkers associated with neurodegenerative disorders with their subsidiary Exosome Sciences, Inc. that may prove to be life-saving for patients. This led to an immediate reaction in the stock market.

The company stock rarely makes percentile movements bigger than 5%, but it managed to get a good 19% gain in the same day the news were announced. The volume wasn’t high and generated only $164 thousand in trade value.

3444LOGO.pngYesterday, however, we saw a bit more attention, but that might be the reason why AEMD made a smaller 10% jump after opening gapped up at $0.25. The interest and the big volume that generated $543 thousand in trade value were probably why the ticker began to slide and closed the session with a price of $0.218.

The company has also filed for a provisional patent entitled, “Brain Specific Exosome Based Diagnostics and Extracorporeal Therapies”, however, there will be some time until we would be able to see if it is approved.

This leaves the stock in a situation where it might go in any direction, depending on near-future press releases. Still, the company is one of the few medical ventures in the OTC markets that has some revenue through government contracts, even though it was operating at a $2.2 million net loss in the quarterly period ended December 31, 2013.

An of course, just like everytime, it will be a good idea to do your due diligence before you make an investment decision.

4ZAAP_chart.pngMicroChannel Technologies Corp. (OTCBB:MCTC) was yesterday’s surprise, as their stock gained a massive 246% in value, after being dull for a long period. ZAP (OTCMKTS:ZAAP) was another big gainer with 306%, but has started today’s session on a bad foot.

You may also like...